Author Correction: Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus

Nat Med. 2023 Nov;29(11):2956. doi: 10.1038/s41591-022-02091-9.

Andreas Mackensen^#^{1

2}, Fabian Müller^#^{1

2}, Dimitrios Mougiakakos^#^{1

2

3}, Sebastian Böltz^{2

4}, Artur Wilhelm^{2

4}, Michael Aigner^{1

2}, Simon Völkl^{1

2}, David Simon^{2

4}, Arnd Kleyer^{2

4}, Luis Munoz^{2

4}, Sascha Kretschmann^{1

2}, Soraya Kharboutli^{1

2}, Regina Gary^{1

2}, Hannah Reimann^{1

2}, Wolf Rösler^{1

2}, Stefan Uderhardt^{2

4}, Holger Bang⁵, Martin Herrmann^{2

4}, Arif Bülent Ekici⁶, Christian Buettner⁶, Katharina Marie Habenicht⁷, Thomas H Winkler⁷, Gerhard Krönke^#^{2

4}, Georg Schett^#^{8

9}

¹ Department of Internal Medicine 5-Hematology and Oncology, Friedrich Alexander University Erlangen-Nuremberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
² Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
³ Department of Hematology and Oncology, Otto-von-Guericke University Magdeburg (OVGU), Magdeburg, Germany.
⁴ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁵ Orgentec, Mainz, Germany.
⁶ Institute of Human Genetics, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany.
⁷ Division of Genetics, Friedrich Alexander University Erlangen-Nuremberg, Erlangen, Germany.
⁸ Deutsches Zentrum für Immuntherapie (DZI), Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.
⁹ Department of Internal Medicine 3-Rheumatology and Immunology, Friedrich Alexander University Erlangen-Nuremberg and Universitätsklinikum Erlangen, Erlangen, Germany. georg.schett@uk-erlangen.de.

^# Contributed equally.

No abstract available

Publication types